uk 68798 has been researched along with Heart Failure in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (17.65) | 18.2507 |
| 2000's | 22 (64.71) | 29.6817 |
| 2010's | 6 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhavnani, SP; Clyne, CA; Coleman, CI; Guertin, D; Kluger, J; Shafi, NA; White, CM; Yarlagadda, RK | 1 |
| Dai, DZ; Dai, Y; Hamed, KH; Hu, C; Yu, F | 1 |
| Abildstrøm, SZ; Køber, L; Pedersen, OD; Schmiegelow, MD; Seibæk, M; Torp-Pedersen, C | 1 |
| Banchs, JE; Baquero, GA; Depalma, S; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, ED; Samii, SM; Wolbrette, DL; Young, SK | 1 |
| Hamlin, RL; Kijtawornrat, A; Sawangkoon, S | 1 |
| Saklani, P; Skanes, A | 1 |
| Cleland, JG; Deedwania, PC; Khand, AU | 1 |
| Singh, BN | 1 |
| Brendorp, B; Elming, H; Køber, L; Torp-Pedersen, C | 1 |
| Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL | 1 |
| Bhatia, GS; Lip, GY | 1 |
| Singer, RB | 1 |
| Roukoz, H; Saliba, W | 1 |
| Møller, M | 1 |
| MacNeil, DJ | 1 |
| Agner, E; Bloch-Thomsen, PE; Camm, AJ; Carlsen, J; Egstrup, K; Køber, L; Marchant, B; Møller, M; Sandøe, E; Torp-Pedersen, C; Videbaek, J | 1 |
| Stevenson, LW; Stevenson, WG | 1 |
| Rubin, SA | 1 |
| Boden, WE; Ferraro, P; Khawari, A | 1 |
| Latini, R | 1 |
| Grines, CL | 1 |
| Bénardeau, A; Li, D; Nattel, S | 1 |
| Camm, AJ; Kober, L; Moller, M; Torp-Pedersen, C | 1 |
| Le Jemtel, TH | 1 |
| Agner, E; Bloch-Thomsen, PE; Carlsen, JE; Egstrup, K; Køber, L; Møller, M; Sandøe, E; Torp-Pedersen, CT; Videbaek, J | 1 |
| Schmitt, C | 1 |
| Doshi, SK; Singh, BN | 1 |
| Brendorp, B; Elming, H; Jensen, GB; Jun, L; Køber, L; Malik, M; Torp-Pedersen, C | 2 |
| Ahn, S; Etienne, J; Friedrich, T; Ghadanfar, M; Massart, PE; Pouleur, H; Rousseau, MF; van Eyll, C | 1 |
| Bagger, H; Keller, N; Køber, L; Marchant, B; Pedersen, OD; Torp-Pedersen, C | 1 |
| Brendorp, B; Elming, H; Jun, L; Køber, L; Torp-Pedersen, C | 1 |
| Mortensen, E; Refsum, H; Yang, T | 1 |
9 review(s) available for uk 68798 and Heart Failure
| Article | Year |
|---|---|
Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dronedarone; Forecasting; Heart Failure; Humans; Phenethylamines; Piperazines; Pyrrolidines; Ranolazine; Sulfonamides; Technology, Pharmaceutical; Ventricular Dysfunction, Left | 2012 |
Prevention of and medical therapy for atrial arrhythmias in heart failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Carbazoles; Carvedilol; Drug Therapy, Combination; Electric Countershock; Heart Failure; Humans; Pacemaker, Artificial; Phenethylamines; Propanolamines; Software Design; Sulfonamides | 2002 |
Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Therapy, Combination; Heart Failure; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 2002 |
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States | 2003 |
Atrial fibrillation post-myocardial infarction: frequency, consequences, and management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Heart Failure; Humans; Incidence; Myocardial Infarction; Phenethylamines; Potassium Channel Blockers; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sulfonamides | 2004 |
Dofetilide: a new class III antiarrhythmic agent.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiologic Techniques, Cardiac; Heart Failure; Humans; Phenethylamines; Randomized Controlled Trials as Topic; Sulfonamides; Tachycardia, Supraventricular; Torsades de Pointes; Ventricular Function, Left | 2007 |
The side effect profile of class III antiarrhythmic drugs: focus on d,l-sotalol.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Conduction System; Heart Failure; Humans; Hypertension; Infant, Newborn; Phenethylamines; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Risk Factors; Sotalol; Sulfonamides; Survival Rate; Torsades de Pointes | 1997 |
Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Failure; Heart Rate; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides | 2000 |
Pure class III antiarrhythmic drugs: focus on dofetilide.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Electrophysiology; Heart Failure; Humans; Phenethylamines; Sulfonamides | 2000 |
10 trial(s) available for uk 68798 and Heart Failure
| Article | Year |
|---|---|
Survival after withdrawal of dofetilide in patients with congestive heart failure and a short baseline QTc interval; a follow-up on the Diamond-CHF QT substudy.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Infant, Newborn; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Proportional Hazards Models; Risk Factors; Sulfonamides; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
DIAMOND antiarrhythmic trials. Danish Investigations of Arrhythmia and Mortality on Dofetilide.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Denmark; Heart Failure; Humans; Myocardial Infarction; Patient Selection; Phenethylamines; Risk; Sulfonamides | 1996 |
Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide.
Topics: Aged; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Denmark; Double-Blind Method; Female; Heart Failure; Humans; Male; Myocardial Infarction; Patient Selection; Phenethylamines; Potassium Channel Blockers; Research Design; Risk Factors; Sulfonamides; Ventricular Dysfunction, Left | 1997 |
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Phenethylamines; Secondary Prevention; Sulfonamides; Survival Analysis; Torsades de Pointes; Ventricular Dysfunction, Left | 1999 |
[Dofetilide in patients with chronic heart failure and left ventricular dysfunction].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Electric Countershock; Female; Follow-Up Studies; Heart Failure; Humans; Male; Phenethylamines; Potassium Channel Blockers; Risk Factors; Sulfonamides; Time Factors; Ventricular Dysfunction, Left | 2000 |
[Dofetilide to patients with heart failure and left ventricular dysfunction].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cause of Death; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Ventricular Dysfunction, Left | 2000 |
Qtc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Double-Blind Method; Female; Heart Failure; Humans; Long QT Syndrome; Male; Middle Aged; Multivariate Analysis; Patient Selection; Phenethylamines; Prospective Studies; Sulfonamides; Survival Analysis; Treatment Outcome; Ventricular Function, Left | 2001 |
Cardiac and hemodynamic effects of intravenous dofetilide in patients with heart failure.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Double-Blind Method; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Long QT Syndrome; Male; Middle Aged; Myocardial Contraction; Phenethylamines; Sulfonamides; Ventricular Function, Left | 2001 |
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Denmark; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Phenethylamines; Sulfonamides; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Follow-Up Studies; Heart Failure; Humans; Long QT Syndrome; Male; Middle Aged; Multivariate Analysis; Observer Variation; Phenethylamines; Potassium Channel Blockers; Prognosis; Reproducibility of Results; Sulfonamides; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
15 other study(ies) available for uk 68798 and Heart Failure
| Article | Year |
|---|---|
The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.
Topics: Aged; Anti-Arrhythmia Agents; Cohort Studies; Confidence Intervals; Connecticut; Defibrillators, Implantable; Digoxin; Electrophysiology; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Phenethylamines; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2010 |
CPU228, a derivative of dofetilide, relieves cardiac dysfunction by normalizing FKBP12.6, NADPH oxidase and protein kinase C epsilon in the myocardium.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Heart Failure; Isoproterenol; Male; NADPH Oxidases; Naphthalenes; Oxidative Stress; Phenethylamines; Phosphorylation; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Sulfonamides; Tacrolimus Binding Proteins; Up-Regulation | 2010 |
Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Cohort Studies; Denmark; Electrocardiography; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2011 |
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dose-Response Relationship, Drug; Electric Countershock; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Phenethylamines; Recurrence; Stroke Volume; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation; Ventricular Function, Left | 2012 |
Assessment of QT-prolonging drugs in the isolated normal and failing rabbit hearts.
Topics: Animals; Arrhythmias, Cardiac; Cisapride; Electrocardiography; Feasibility Studies; Glucose; Heart; Heart Failure; In Vitro Techniques; Male; Models, Animal; Phenethylamines; Quinidine; Rabbits; Sulfonamides; Torsades de Pointes; Tromethamine | 2012 |
Mortality in two recent reports of clinical trials on patients with congestive heart failure compared with mortality in three previous clinical trials.
Topics: Aged; Anti-Arrhythmia Agents; Clinical Trials as Topic; Denmark; Diuretics; Female; Heart Failure; Humans; Life Tables; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Phenethylamines; Placebos; Spironolactone; Sulfonamides; United States | 2000 |
Atrial fibrillation in heart failure.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Failure; Humans; Phenethylamines; Sulfonamides | 1999 |
Dofetilide for atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart Failure; Hospitalization; Humans; Phenethylamines; Sulfonamides; Torsades de Pointes | 2000 |
Dofetilide for atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Drug Interactions; Drug Therapy, Combination; Heart Failure; Humans; Phenethylamines; Sulfonamides | 2000 |
Safety and effectiveness of dofetilide for conversion of atrial fibrillation and nesiritide for acute decompensation of heart failure: a report from the cardiovascular and renal advisory panel of the Food and Drug Administration.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Natriuretic Factor; Cardiovascular Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Therapeutic Equivalency | 2000 |
Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Disease Models, Animal; Dogs; Electrocardiography; Heart Failure; Heart Ventricles; Pacemaker, Artificial; Pericardium; Phenethylamines; Sulfonamides; Ventricular Remodeling | 2000 |
Management of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Heart Failure; Humans; Myocardial Revascularization; Phenethylamines; Ramipril; Randomized Controlled Trials as Topic; Sulfonamides; Ventricular Dysfunction, Left | 2000 |
[Heart failure and sudden cardiac death: pharmacological and nonpharmacological treatment possibilities from the viewpoint of the rhythmologist].
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiac Pacing, Artificial; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Follow-Up Studies; Heart Failure; Humans; Multicenter Studies as Topic; Phenethylamines; Potassium Channel Blockers; Randomized Controlled Trials as Topic; Risk Factors; Sulfonamides; Vasodilator Agents | 2000 |
Qt dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Denmark; Double-Blind Method; Electrocardiography; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Observer Variation; Phenethylamines; Prognosis; Sulfonamides; Survival Analysis; Ventricular Dysfunction, Left | 2001 |
Class III antiarrhythmic action and inotropy: effects of dofetilide in acute ischemic heart failure in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Dogs; Electrocardiography; Female; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Phenethylamines; Stimulation, Chemical; Sulfonamides | 1992 |